Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Varn

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Genome Biology|February 7, 2024
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapyGeorgette Tanner, Rhiannon Barrow, Shoaib Ajaib, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Cancer Cell|February 13, 2020
Comparative Molecular Life History of Spontaneous Canine and Human GliomasSamirkumar B Amin, Kevin J Anderson, C Elizabeth Boudreau, et al.
Nature Genetics|May 9, 2025
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomicsAvishay Spitzer, Kevin C Johnson, Masashi Nomura, et al.
Nature Genetics|May 9, 2025
The multilayered transcriptional architecture of glioblastoma ecosystemsMasashi Nomura, Avishay Spitzer, Kevin C Johnson, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
Cell|June 1, 2022
Glioma progression is shaped by genetic evolution and microenvironment interactionsFrederick S Varn, Kevin C Johnson, Jan Martinek, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomasTamrin Chowdhury, C Mircea S Tesileanu, Emre Kocakavuk, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Genome Biology|February 7, 2024
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapyGeorgette Tanner, Rhiannon Barrow, Shoaib Ajaib, et al.
Cell Reports. Medicine|March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomasYouri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Cancer Cell|February 13, 2020
Comparative Molecular Life History of Spontaneous Canine and Human GliomasSamirkumar B Amin, Kevin J Anderson, C Elizabeth Boudreau, et al.
Nature Genetics|May 9, 2025
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomicsAvishay Spitzer, Kevin C Johnson, Masashi Nomura, et al.
Nature Genetics|May 9, 2025
The multilayered transcriptional architecture of glioblastoma ecosystemsMasashi Nomura, Avishay Spitzer, Kevin C Johnson, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
Cell|June 1, 2022
Glioma progression is shaped by genetic evolution and microenvironment interactionsFrederick S Varn, Kevin C Johnson, Jan Martinek, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomasTamrin Chowdhury, C Mircea S Tesileanu, Emre Kocakavuk, et al.
Pageof 5